Compounds > bexarotene
Page last updated: 2024-08-25

bexarotene and Lymphoma, T Cell, Peripheral

bexarotene has been researched along with Lymphoma, T Cell, Peripheral in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnoldi, S; Bagg, A; Chong, E; Nasta, S; Schuster, SJ; Svoboda, J; Tsai, DE1
Aqui, NA; Bloom, RD; Nasta, SD; Schuster, SJ; Tsai, DE; Vogl, DT; Wasik, MA1

Other Studies

2 other study(ies) available for bexarotene and Lymphoma, T Cell, Peripheral

ArticleYear
Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:9

    Topics: Antineoplastic Agents; Bexarotene; Female; Humans; Lymphoma, T-Cell, Peripheral; Middle Aged; Retinoid X Receptors; Tetrahydronaphthalenes; Treatment Outcome

2011
Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid analog bexarotene.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2005, Volume: 5, Issue:8

    Topics: Anticarcinogenic Agents; Bexarotene; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Postoperative Complications; Tetrahydronaphthalenes; Viral Load

2005